Jim Cramer Advises Viewers On AstraZeneca, Juno Therapeutics, Enbridge Energy Partners, Lockheed Martin And Microsoft
March 09, 2016 at 07:02 AM EST
On CNBC's Mad Money, Jim Cramer said that AstraZeneca plc (ADR) (NYSE: AZN) is in the midst of a major change and it has a nice ...